Clémentine Perrier

Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial

Séverine Vermeire, Sharon O’Byrne, Mary Keir et al. · The Lancet · 2014 · 449 citations · Full text

<i>Butyricicoccus pullicaecorum</i> in inflammatory bowel disease

Venessa Eeckhaut, Kathleen Machiels, Clémentine Perrier et al. · Gut · 2012 · 359 citations

Predictive value of epithelial gene expression profiles for response to infliximab in Crohnʼs disease‡

Ingrid Arijs, Roel Quintens, Leentje Van Lommel et al. · Inflammatory Bowel Diseases · 2010 · 161 citations

Rotavirus Anti-VP6 Secretory Immunoglobulin A Contributes to Protection via Intracellular Neutralization but Not via Immune Exclusion

Blaise Corthésy, Yann Bénureau, Clémentine Perrier et al. · Journal of Virology · 2006 · 125 citations · Full text

Molecular Virology, Autoimmune Disease, Immune Exclusion +15

Glycans on Secretory Component Participate in Innate Protection against Mucosal Pathogens

Clémentine Perrier, Norbert Sprenger, Blaise Corthésy · Journal of Biological Chemistry · 2006 · 112 citations · Full text

Protein Secretion, Microbial Pathogens, Innate Immune System +25